NEOG
NEOGEN CORP
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$12.99
+1.25%Forward multiples
Based on analyst estimates
- P/E forward
- 63.89x
- P/E 2026E
- 41.71x
- P/E 2027E
- 31.54x
- P/E 2028E
- 28.11x
- P/S forward
- 3.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.35x
- Price / sales
- 3.26x
- Price / cash flow
- 34.05x
Enterprise value
- Enterprise value
- $3.4B
- EV / sales
- 3.95x
- EV / EBITDA
- 20.00x
- EV / EBIT
- -158.81x
- Market cap
- $2.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of May 1, 2026